التداخل بين كلوميبرامين وفلوكسيتين
كلوميبرامين وفلوكسيتين: كلتا نشرتَي الوصف تنبّهان إلى هذا الجمع بأشد العبارات، مثل مانع استعمال أو تحذير مؤطر أو تعليمات بتجنّبه.
لا تجمع بينهما دون توجيه من الطبيب الواصف. عبارات النشرة الواردة أدناه هي أشد ما تستخدمه FDA.
ما تقوله نشرات FDA
من نشرة فلوكسيتين (Prozac) · تاريخ السريان 2026-01-08
If concomitant use of PROZAC with other serotonergic drugs is clinically warranted, patients should be made aware of a potential increased risk for serotonin syndrome, particularly during treatment initiation and dose increases ( 5.2 )
If concomitant use of PROZAC with other serotonergic drugs is clinically warranted, inform patients of the increased risk for serotonin syndrome and monitor for symptoms.
If serotonin syndrome occurs, consider discontinuation of PROZAC and/or concomitant serotonergic drugs [see Warnings and Precautions ( 5.2 )] .
The risk is increased with concomitant use of other serotonergic drugs (including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, meperidine, methadone, buspirone, amphetamines, and St.
Tricyclic Antidepressants (TCAs): Monitor TCA levels during coadministration with PROZAC or when PROZAC has been recently discontinued ( 5.2 , 7.7 )
من نشرة كلوميبرامين (CLOMIPRAMINE HYDROCHLORIDE) · تاريخ السريان 2024-11-26
Anyone considering the use of clomipramine hydrochloride or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need.
CONTRAINDICATIONS Clomipramine hydrochloride capsules are contraindicated in patients with a history of hypersensitivity to clomipramine hydrochloride capsules or other tricyclic antidepressants.
…several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well.
Nevertheless, caution is indicated in the co-administration of TCAs with any of the SSRIs and also in switching from one class to the other.
Monoamine Oxidase Inhibitors (MAOIs) ( See CONTRAINDICATIONS , WARNINGS , and DOSAGE AND ADMINISTRATION .) Serotonergic Drugs ( See CONTRAINDICATIONS , WARNINGS , and DOSAGE AND ADMINISTRATION .)
هل تتناول أكثر من هذين الاثنين؟ التداخلات تتراكم. افحص قائمتك كاملة دفعة واحدة؛ وهي تبقى في متصفحك.
افتح في الفاحصليست نصيحة طبية. يقتبس Interaction Checker نص نشرات FDA وصحائف الوقائع الصادرة عن NIH. وأهمية التداخل في حالتك تتوقف على الجرعات والتوقيت ووظائف الكلى والكبد والحالات الصحية الأخرى. تأكّد من ذلك مع صيدلي أو مع الطبيب الواصف.